114 related articles for article (PubMed ID: 6577229)
21. [Effect of 3 months of thioacetamide treatment on liver biotransformation in vivo and in vitro (various times after discontinuation)].
Lattermann K; Kraul H; Hoffmann A
Gastroenterol J; 1990; 50(4):190-4. PubMed ID: 2091675
[TBL] [Abstract][Full Text] [Related]
22. Early liver cell lesions in rats induced by thioacetamide. An ultrastructural, cytophotometric and autoradiographic study.
Marleen P; Hendrik R; van Oostveldt P
Pathol Res Pract; 1988 Dec; 184(1):69-76. PubMed ID: 2466281
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of experimentally induced cirrhosis in rats by hypothyroidism.
Oren R; Dotan I; Papa M; Marravi Y; Aeed H; Barg J; Zeidel L; Bruck R; Halpern Z
Hepatology; 1996 Aug; 24(2):419-23. PubMed ID: 8690414
[TBL] [Abstract][Full Text] [Related]
24. Thioacetamide-induced intestinal-type cholangiocarcinoma in rat: an animal model recapitulating the multi-stage progression of human cholangiocarcinoma.
Yeh CN; Maitra A; Lee KF; Jan YY; Chen MF
Carcinogenesis; 2004 Apr; 25(4):631-6. PubMed ID: 14656942
[TBL] [Abstract][Full Text] [Related]
25. Similitudes and differences in the reactivity of the liver cell chromatin to thioacetamide and hydrocortisone. Electron microscopic and cytochemical quantitative data concerning the chromatin condensation-dispersion cycle.
Moraru I; Dragomir CT; Tomescu E; Cotutiu C; Ungureanu D
Pathol Eur; 1974; 9(4):317-23. PubMed ID: 4142077
[TBL] [Abstract][Full Text] [Related]
26. Persistence of liver cirrhosis in association with proliferation of nonparenchymal cells and altered location of alpha-smooth muscle actin-positive cells.
Kang JS; Morimura K; Salim EI; Wanibuchi H; Yamaguchi S; Fukushima S
Toxicol Pathol; 2005; 33(3):329-35. PubMed ID: 15814362
[TBL] [Abstract][Full Text] [Related]
27. A sequential study of methapyrilene hydrochloride-induced liver carcinogenesis in male F344 rats.
Ohshima M; Ward JM; Brennan LM; Creasia DA
J Natl Cancer Inst; 1984 Mar; 72(3):759-68. PubMed ID: 6583458
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of TGFbeta1 and leptin ameliorates thioacetamide-induced liver injury in lipopolysaccharide-primed rats.
Chen HN; Fan S; Weng CF
J Endotoxin Res; 2007; 13(3):176-88. PubMed ID: 17621560
[TBL] [Abstract][Full Text] [Related]
29. Role of carnosine in preventing thioacetamide-induced liver injury in the rat.
Mehmetçik G; Ozdemirler G; Koçak-Toker N; Cevikbaş U; Uysal M
Peptides; 2008 Mar; 29(3):425-9. PubMed ID: 18164100
[TBL] [Abstract][Full Text] [Related]
30. Application of metabonomics on an experimental model of fibrosis and cirrhosis induced by thioacetamide in rats.
Constantinou MA; Theocharis SE; Mikros E
Toxicol Appl Pharmacol; 2007 Jan; 218(1):11-9. PubMed ID: 17113614
[TBL] [Abstract][Full Text] [Related]
31. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
32. Histogenesis of cholangiomas and cholangiocarcinomas in thioacetamide fed rats.
Praet MM; Roels HJ
Exp Pathol; 1984; 26(1):3-14. PubMed ID: 6207043
[TBL] [Abstract][Full Text] [Related]
33. Structure and importance of intranuclear inclusions in thioacetamide hepatocarcinogenesis.
Kendrey G
Acta Morphol Acad Sci Hung; 1968; 16(1):53-63. PubMed ID: 5684974
[No Abstract] [Full Text] [Related]
34. Late preventive effects on dimethylnitrosamine, thioacetamide or galactosamine-induced liver necrosis of the inhibitor of proteases, phenylmethylsulfonyl fluoride.
de Ferreyra EC; de Fenos OM; Castro JA
Res Commun Chem Pathol Pharmacol; 1983 Dec; 42(3):505-8. PubMed ID: 6665306
[TBL] [Abstract][Full Text] [Related]
35. Beta-carotene attenuates experimentally induced liver cirrhosis in rats.
Wardi J; Reifen R; Aeed H; Zadel L; Avni Y; Bruck R
Isr Med Assoc J; 2001 Feb; 3(2):151-4. PubMed ID: 11344828
[TBL] [Abstract][Full Text] [Related]
36. Curcumin ameliorates acute thioacetamide-induced hepatotoxicity.
Shapiro H; Ashkenazi M; Weizman N; Shahmurov M; Aeed H; Bruck R
J Gastroenterol Hepatol; 2006 Feb; 21(2):358-66. PubMed ID: 16509859
[TBL] [Abstract][Full Text] [Related]
37. Simvastatin for rats with thioacetamide-induced liver failure and encephalopathy.
Huang HC; Wang SS; Lee FY; Chan CY; Chang FY; Lin HC; Chu CJ; Chen YC; Lee SD
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e236-42. PubMed ID: 17573832
[TBL] [Abstract][Full Text] [Related]
38. Thioacetamide-stimulated expression of non-histone protein.
Krajewska WM; Marszałek M; Gaczyński M; Kłyszejko-Stefanowicz L
Cytobios; 1993; 75(301):103-12. PubMed ID: 8404030
[TBL] [Abstract][Full Text] [Related]
39. NTP Toxicology and Carcinogenesis Studies of Ethylene Thiourea (CAS: 96-45-7) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1992 Mar; 388():1-256. PubMed ID: 12637971
[TBL] [Abstract][Full Text] [Related]
40. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
